A New Model To Accelerate Innovation
ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the world’s most innovative scientists and inventors. Together, we leverage our internal bench-to-bedside expertise to accelerate the development and delivery of therapies – supported by our broad access to capital.
Many Companies – One Robust Organization
ElevateBio’s novel business model, including BaseCamp, our centralized R&D and manufacturing organization, is structured to rapidly and efficiently build single- and multi-product cell and gene therapy companies. Each portfolio company benefits from our fully-integrated capabilities, including basic and translational research, process development, cGMP manufacturing, clinical development, regulatory affairs and commercial operations.